bms-191011 (d16d0b52-31c6-40c1-85a9-49d695221865) (Collection)

Project:

Drugmonizome

Dcc Asset:

IDG C2M2 2024-01-09 datapackage validated.zip

Dcc:

IDG

Compound:

3-(5-Chloro-2-hydroxybenzyl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one

Collection:

d16d0b52-31c6-40c1-85a9-49d695221865.json

Persistent Id:d16d0b52-31c6-40c1-85a9-49d695221865.json

Description:Metadatata for bms-191011

Creation Time:2021-09-08T00:00:00

Linked to

	Label	Description
	3-(5-Chloro-2-hydroxybenzyl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one Compound (Entity type)	nan
	d16d0b52-31c6-40c1-85a9-49d695221865.json File (Entity type)	A file from IDG as part of the Drugmonizome project

3-(5-Chloro-2-hydroxybenzyl)-5-(4-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2(3H)-one

nan

d16d0b52-31c6-40c1-85a9-49d695221865.json

A file from IDG as part of the Drugmonizome project

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.